|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400084658 |
|
最近更新日期: Date of Last Refreshed on: |
2024-05-22 10:42:39 |
|
注册时间: Date of Registration: |
2024-05-22 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
“H3H”全程营养管理模式对结直肠癌受试者术后营养状况和预后结局的影响 |
|
Public title: |
Effect of the Home to Hospital to Home nutrition management program on postoperative nutritional status and prognosis with colorectal cancer patients: A single-center randomized controlled study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
“H3H”全程营养管理模式对结直肠癌受试者术后营养状况和预后结局的影响 |
|
Scientific title: |
Effect of the Home to Hospital to Home nutrition management program on postoperative nutritional status and prognosis with colorectal cancer patients: A single-center randomized controlled study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王婉萍 |
研究负责人: |
汤东 |
|
Applicant: |
Wanping Wang |
Study leader: |
Dong Tang |
|
申请注册联系人电话: Applicant telephone: |
+86 153 4922 4592 |
研究负责人电话:
Study leader's |
+86 189 5278 3556 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2996383200@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
83392785@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省扬州市广陵区南通西路98号 |
研究负责人通讯地址: |
江苏省扬州市广陵区南通西路98号 |
|
Applicant address: |
No. 98, Nantong West Road, Guangling District, Yangzhou City, Jiangsu ProvinceDistrict, Yangzhou City, Jiangsu Province |
Study leader's address: |
No. 98, Nantong West Road, Guangling District, Yangzhou City, Jiangsu ProvinceDistrict, Yangzhou City, Jiangsu Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
苏北人民医院 |
||
|
Applicant's institution: |
Northern Jiangsu People's Hospital |
||
|
研究负责人所在单位: |
苏北人民医院 |
||
|
Affiliation of the Leader: |
Northern Jiangsu People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024ky088 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
苏北人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Northern Jiangsu People's Hospital Medical Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-15 00:00:00 | ||
|
伦理委员会联系人: |
何艳燕 |
||
|
Contact Name of the ethic committee: |
Yanyan He |
||
|
伦理委员会联系地址: |
江苏省扬州市广陵区南通西路98号 |
||
|
Contact Address of the ethic committee: |
No. 98, Nantong West Road, Guangling District, Yangzhou City, Jiangsu Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 514 8737 3694 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
sbyyll2012@163.com |
|
研究实施负责(组长)单位: |
苏北人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Northern Jiangsu People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省扬州市广陵区南通西路98号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 98, Nantong West Road, Guangling District, Yangzhou City, Jiangsu ProvinceDistrict, Yangzhou City, Jiangsu Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
研究者发起的临床试验 |
||||||||||||||||||||||
|
Source(s) of funding: |
Investigator-initiated clinical trials |
||||||||||||||||||||||
|
研究疾病: |
结直肠癌 |
||||||||||||||||||||||
|
Target disease: |
colorectal cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
主要目的:评估“H3H”营养管理模式对结直肠癌受试者营养状况的影响。 次要目的:评估“H3H”营养管理模式对结直肠癌受试者预后结局的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Objective: To evaluate the effect of "H3H" nutrition management model on the nutritional status of subjects with colorectal cancer. Secondary objective: To evaluate the effect of "H3H" nutrition management model on the prognosis of subjects with colorectal cancer. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1: 经过病理组织学和影像学等确诊为结直肠癌 2: 年龄>18岁 3: 预计生存时间在6个月以上 4: 需行结直肠癌局部切除或根治术 5: 接受过文化教育 |
||||||||||||||||||||||
|
Inclusion criteria |
1: The diagnosis of colorectal cancer was confirmed by histopathology and imaging 2: Age > 18 years old 3: The expected survival time is more than 6 months 4: Local resection or radical resection of colorectal cancer is required 5: Have received cultural education |
||||||||||||||||||||||
|
排除标准: |
1: 依从性较差,不愿意配合本次研究 2: 正在参与其他营养干预研究 3: 自身免疫性疾病 4: 合并其他脏器的恶性肿瘤 5: 不适合人体成分测量者:安装心脏起搏器者,足踝角质层过厚者,体内有金属物质 |
||||||||||||||||||||||
|
Exclusion criteria: |
1: Poor compliance and were unwilling to cooperate with this study 2: Is participating in other nutritional intervention studies 3: Autoimmune diseases 4: malignant tumors in other organs 5: Not suitable for body composition measurement: pacemaker, ankle cuticle is too thick, the body has metal substances |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-06-01 00:00:00至 To 2025-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-06-01 00:00:00 至 To 2025-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由统计人员设计产生随机序列,受试者按照签署知情同意书的时间顺序接受从小到大编号,受试者的编号和随机序号一一对应 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A random sequence was designed and generated by statistician and the subjects received numbering from small to large in the chronological order of signing the informed consent form. The subject's number corresponds one-to-one with the random number. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
单盲(只对受试者设盲) |
|
Blinding: |
Single-blind (subjects only) |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据向负责人合理要求获得 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The original data can be obtained upon reasonable request to the person in charge |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子病例记录表和Excel表格 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF and Excel |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |